Friday, August 1, 2025

CloudMD Hits $39.2 Million In Revenue, $4.3 Million Net Loss In Q3 2021

CloudMD Software & Services Inc. (TSXV: DOC) released on Monday its Q3 2021 financial results which saw the company post quarterly revenue of $39.2 million, as expected from the preliminary results the firm previously announced. This is an increase from Q2 2021’s revenue of $15.7 million and Q3 2020’s revenue of $3.4 million.

“This was a milestone quarter for CloudMD as it’s the first quarter we recognized full revenue contributions from all the recently closed acquisitions and clearly demonstrated that our whole-person, patient-centric approach to healthcare is working,” explained CloudMD CEO Dr. Essam Hamza. The company completed 4 acquisitions in the preceding quarter and 14 acquisitions in the last twelve months. 

Currently, the company said it has increased its annual revenue run rate to over $185.0 million, higher than the $155.0 million it previously announced in the preliminary results.

Looking at the financials, the gross margin for the quarter was at 34.0%, down from 35.5% last quarter and 37.5% last year. This is being attributed to the current revenue mix with lower-margin businesses taking 32% of the revenue share.

However, the firm still ended the quarter with a $4.3 million net loss compared to a $6.0 million net loss last quarter and a $2.7 million net loss last year. This quarter’s loss translates to $0.02 per share.

On the other hand, the company recorded its first positive adjusted EBITDA this quarter with $0.8 million coming from a loss of $0.7 million last quarter and $1.3 million last year.

The firm also ended the quarter with $53.7 million in cash and cash equivalents coming from a beginning balance of $60.9 million. This brings current assets balance to $82.5 million while current liabilities ended at $49.9 million.

The healthtech firm relayed that with the proposed $116.0 million acquisition of MindBeacon Holdings (TSX: MBCN), it expects to have over $60.0 million in cash and cash equivalents. Following this, Cannacord lowered their 12-month price target for the company from $3.50 to $3.00.

CloudMD Software & Services Inc. last traded at $1.33 on the TSX Venture.


Information for this briefing was found via Sedar and CloudMD Software & Services. The author has no securities related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Gold’s Bull Run May Just Be Getting Started! | Peter Grandich

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

CloudMD Releases Preliminary Q3 Results

CloudMD Software & Services (TSXV: DOC) has released preliminary third quarter financial results this morning....

Tuesday, November 9, 2021, 09:02:00 AM

CloudMD Gets Price Target Cut By Canaccord Genuity

On Monday CloudMD Software & Services Inc. (TSXV: DOC) reported its fourth quarter results for...

Wednesday, May 4, 2022, 03:06:00 PM

CloudMD: Canaccord Lowers Revenue Estimates, Maintains Ratings

On May 28th, CloudMD Software & Services Inc. (TSXV: DOC) reported its first-quarter financial results....

Monday, May 31, 2021, 10:31:00 AM

Trudeau: Virtual Health Care and Antibody Research to Receive More Than $240M

In a Sunday announcement, Canadian Prime Minister announced the federal government will spend more than...

Sunday, May 3, 2020, 04:00:18 PM

CloudMD Closes First Tranche Of Financing For $2.3 Million

CloudMD Software & Services (CSE: DOC) announced this morning that it will be closing the...

Wednesday, March 18, 2020, 08:40:07 AM